SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRPRNewsWire • 04/28/25
Unveiling Astrazeneca (AZN) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 04/24/25
Tempus AI shares jump on new oncology AI partnerships with AstraZeneca, PathosProactive Investors • 04/23/25
Tempus Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in OncologyBusiness Wire • 04/23/25
AstraZeneca CEO says Europe must protect its health sovereignty, is falling behind on pharma investmentsReuters • 04/23/25
Astrazeneca (AZN) Rises But Trails Market: What Investors Should KnowZacks Investment Research • 04/22/25
AstraZeneca reports best trial results in a decade for metastatic breast cancer treatmentProactive Investors • 04/22/25
Should You Buy, Sell or Hold AstraZeneca Stock Before Q1 Earnings?Zacks Investment Research • 04/21/25
The Zacks Analyst Blog AbbVie's, Rinvoq and AstraZeneca's and NovartisZacks Investment Research • 04/14/25
AstraZeneca's quarterly earnings may undershoot; tariffs and a trade war pose the bigger obstacleProactive Investors • 04/10/25
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on TariffsZacks Investment Research • 04/10/25
AstraZeneca and GSK retain defensive qualities, but tariff assault on sector could change thatProactive Investors • 04/10/25
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkbackCNBC • 04/10/25
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play OutSeeking Alpha • 04/09/25